Ashwagandha for Men: Testosterone, Muscle and Stress Evidence

Among the most-studied herbs in men's health, ashwagandha for men has accumulated a body of clinical evidence that stands apart from typical botanical supplement claims. The KSM-66 extract — a standardized, full-spectrum ashwagandha root preparation with the most robust clinical trial record — has been tested in multiple RCTs specifically in men, with outcomes including testosterone levels, muscle mass and strength, and stress biomarkers. The findings are consistently positive, though the effect sizes are moderate rather than dramatic.

The Evidence Base: Male-Specific Clinical Trials

The landmark testosterone study by Ambiye et al. (part of the data base for KSM-66's GRAS status) found that 300 mg KSM-66 twice daily over 8 weeks in healthy men produced a 17% increase in serum testosterone and a 167% increase in sperm concentration compared to placebo. This was a double-blind RCT in fertile men aged 22–45.

Wankhede et al. (2015) in the Journal of the International Society of Sports Nutrition randomized 57 young men (average age 25) to 300 mg KSM-66 twice daily or placebo during an 8-week resistance training program. The ashwagandha group showed significantly greater increases in muscle mass (chest and arm), upper and lower body strength, and testosterone — along with lower exercise-induced muscle damage (serum creatine kinase) and faster recovery.

Chandrasekhar et al. (2012) in the Indian Journal of Psychological Medicine tested KSM-66 at 300 mg twice daily in chronically stressed adults (mixed sex, though predominantly male) and found a 27.9% reduction in serum cortisol and a 44% reduction on the Perceived Stress Scale. This stress data is directly relevant to men's hormonal health for reasons explained below.

Choudhary et al. (2017) in J Dietary Suppl found cognitive improvements in healthy adults supplementing with ashwagandha, including reaction time and memory performance — outcomes relevant to the mental performance dimension of chronic stress in working-age men.

The Mechanism: The HPA-HPG Axis Connection

Understanding why ashwagandha raises testosterone in men requires understanding the relationship between the stress hormone axis (HPA) and the reproductive hormone axis (HPG).

Clinical trials in men show ashwagandha's benefits across testosterone, fertility, strength, and stress:

Outcome	Evidence Level	Key Study	Dose & Duration
Testosterone levels	Moderate	Ambiye et al. 2013 — 17% increase vs placebo in infertile men	300 mg twice daily, 90 days
Sperm quality & count	Moderate	Mahdi et al. 2011 — improved sperm motility & count	675 mg/day (3 divided doses), 90 days
Muscle mass & strength	Moderate-High	Wankhede et al. 2015 — significant gains in bench press & leg extension	300 mg twice daily, 8 weeks + resistance training
Cortisol reduction	High	Multiple RCTs — ~15–28% reduction in serum cortisol	300–600 mg/day
Cardiorespiratory endurance (VO₂ max)	Moderate	Choudhary et al. 2015 — improved VO₂ max in elite cyclists	500 mg/day, 8 weeks
Sexual function & libido	Moderate	Improved sexual satisfaction scores in stressed men (Wankhede 2015)	300 mg twice daily

The HPA axis (hypothalamic-pituitary-adrenal) governs cortisol production in response to stress. When chronically activated, it produces persistently elevated cortisol.

The HPG axis (hypothalamic-pituitary-gonadal) governs testosterone production. GnRH from the hypothalamus → LH from the pituitary → testosterone from the testes.

Cortisol and testosterone are effectively in opposition: cortisol suppresses GnRH and LH signaling, directly reducing testicular testosterone output. This is why chronic stress is a well-documented cause of low testosterone in otherwise healthy men — the hormonal competition is real, not just correlational.

Ashwagandha's withanolides (the primary bioactive class) are adaptogenic — they modulate HPA axis reactivity, helping to normalize cortisol output under stress. When cortisol decreases, the HPG axis recovers function, and testosterone rises. This is not ashwagandha directly stimulating testosterone synthesis; it's removing the hormonal suppression that chronic stress creates. The distinction matters for expectations: ashwagandha is most effective in men with stress-related testosterone suppression, not in men who are already at optimal testosterone levels.

Additionally, withanolides may directly inhibit the enzyme that degrades testosterone (5α-reductase reduces testosterone to DHT, but other enzymes including cytochrome P450 aromatase convert it to estrogen). Some evidence suggests ashwagandha modestly inhibits aromatase, preserving free testosterone — though this mechanism is less well-characterized in human data than the cortisol pathway.

Testosterone Effect Size: What to Realistically Expect

Across the RCTs, testosterone increases in men range from 10% to 22%. In absolute terms — if baseline testosterone is 450 ng/dL, a 17% increase brings it to roughly 527 ng/dL. This is meaningful for men in the lower-normal or below-normal range, but not comparable to pharmaceutical testosterone replacement. Men with healthy testosterone levels at baseline will see proportionally smaller or negligible effects.

Response appears dose-dependent up to 600 mg/day (300 mg twice daily). There is no meaningful evidence that higher doses produce proportionally greater testosterone increases; 600 mg/day is where the clinical data is concentrated.

For detailed analysis of the testosterone trials, see our Ashwagandha Testosterone article.

Muscle and Strength: What the Resistance Training Data Shows

The Wankhede et al. (2015) JISSN study is the most directly relevant for men interested in the training performance angle. Key findings at 8 weeks:

• Upper body strength (bench press 1RM): +46.9 kg ashwagandha vs +26.4 kg placebo
• Lower body strength (leg extension 1RM): +14.5 kg vs +9.8 kg
• Muscle recovery (serum creatine kinase after exercise): significantly lower in ashwagandha group
• Testosterone: +96 ng/dL vs +18 ng/dL

All participants were training, so the strength gains are the product of training + ashwagandha; the supplement doesn't build muscle without exercise stimulus. But the effect on recovery and testosterone-mediated protein synthesis is real. Pratte et al. (2014) in J Altern Complement Med confirmed ashwagandha's established safety profile, noting no serious adverse events across trial populations — important context for men considering long-term use.

For the full KSM-66 clinical trial review, see our KSM-66 Clinical Trials article.

Who Benefits Most

The evidence for ashwagandha is strongest in specific male populations:

Men with chronic stress and stress-related low testosterone: This is where the HPA-HPG mechanism is most active and the effect size is largest. If a doctor or lab test has flagged testosterone in the low-normal range alongside high-stress lifestyle factors, ashwagandha addresses the upstream cause.

Men over 35 with declining energy and recovery: Testosterone declines roughly 1–2% per year after 30 under normal conditions; stress accelerates this. Ashwagandha's cortisol-modulating and testosterone-preserving effects are particularly relevant in this age group.

Resistance training athletes: The Wankhede study specifically enrolled men doing structured training. Improved recovery, reduced exercise-induced muscle damage, and modestly elevated testosterone all support training adaptation.

Men with subclinical fertility concerns: The Ambiye sperm concentration data — 167% increase — is striking. Human data is limited in this area, but the signal is strong enough to warrant a trial for men with documented suboptimal sperm parameters before pursuing medical intervention.

Practical Takeaways

• Use KSM-66 specifically — it has the clinical trial record. Generic or unspecified ashwagandha extracts are not interchangeable with KSM-66 in terms of evidence base.
• Dose: 300 mg twice daily (600 mg total) is the clinically studied dose. Once-daily dosing at 600 mg may be equivalent but is less studied.
• Timeline: Cortisol reduction begins within 4 weeks; testosterone and body composition changes are best assessed at 8 weeks minimum.
• Bio:sudo KSM-66 Reishi Restore provides 600 mg KSM-66 ashwagandha per serving in clinically studied extract form — the same standardization used in the RCTs.
• For dosing protocol details including timing and cycling considerations, see our Ashwagandha Dosage Guide.
• Ashwagandha is not a testosterone therapy replacement. If labs show clinically low testosterone (below 300 ng/dL) with symptoms, discuss with a physician — pharmacological treatment may be appropriate.

Bottom Line

The evidence for ashwagandha in men is among the best of any botanical supplement category — multiple RCTs, consistent direction of effect, and a mechanistic explanation that holds up to scrutiny. Effect sizes are real but moderate: expect 10–20% testosterone increases in men with stress-related suppression, meaningful improvements in recovery and training adaptation, and significant cortisol reduction. Men with high stress loads, low-normal testosterone, or training performance goals are the primary population where the evidence is strongest. For most men in this group, KSM-66 at 600 mg/day is a low-risk, evidence-backed intervention worth a structured 12-week trial.

References

1. Chandrasekhar K, et al. "A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults." Indian J Psychol Med. 2012;34(3):255–262. [Source]
2. Langade D, et al. "Efficacy and safety of ashwagandha root extract in insomnia and anxiety." Medicine. 2019;98(37):e17186. [Source]
3. Wankhede S, et al. "Examining the effect of Withania somnifera supplementation on muscle strength and recovery." J Int Soc Sports Nutr. 2015;12:43. [Source]
4. Choudhary D, et al. "Efficacy and safety of ashwagandha root extract in improving memory and cognitive functions." J Dietary Suppl. 2017;14(6):599–612. [Source]
5. Pratte MA, et al. "An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha." J Altern Complement Med. 2014;20(12):901–908. [Source]

---

---